APA (7th ed.) Citation

Azevedo-Silva, J., Tavares-Valente, D., Almeida, A., Queiros, O., Baltazar, F., Ko, Y. H., . . . Casal, M. (2022). Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: Implications in cancer therapy.

Chicago Style (17th ed.) Citation

Azevedo-Silva, J., D. Tavares-Valente, A. Almeida, O. Queiros, Fátima Baltazar, Y. H. Ko, P. L. Pedersen, Ana Preto, and Margarida Casal. Cytoskeleton Disruption by the Metabolic Inhibitor 3-bromopyruvate: Implications in Cancer Therapy. 2022.

MLA (8th ed.) Citation

Azevedo-Silva, J., et al. Cytoskeleton Disruption by the Metabolic Inhibitor 3-bromopyruvate: Implications in Cancer Therapy. 2022.